| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/26/2000 | EP0973705A1 Chromatographic enantiomer separation of lactones |
| 01/26/2000 | EP0973550A1 Antagonistic anti-avb3 integrin antibodies |
| 01/26/2000 | EP0973538A1 Modified proteins which bind extracellular matrix components |
| 01/26/2000 | EP0973536A1 Restenosis/atherosclerosis diagnosis, prophylaxis and therapy |
| 01/26/2000 | EP0973530A1 Serum-derived factor inducing cell differentiation and medical uses thereof |
| 01/26/2000 | EP0973512A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 01/26/2000 | EP0973511A1 Use of sibutramine analogues to lower lipid levels |
| 01/26/2000 | EP0973392A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 01/26/2000 | EP0973390A1 Retinoid related molecules for the inhibition of endothelin-1 overproduction in disease |
| 01/26/2000 | EP0791006B1 Polyanionic benzylglycosides as inhibitors of smooth muscle cell proliferation |
| 01/26/2000 | EP0650484B1 Endothelin receptor antagonists |
| 01/26/2000 | CN1242772A Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine |
| 01/26/2000 | CN1242768A Antithrombotic organic nitrates |
| 01/26/2000 | CN1242374A Process for extracting ginsenoside Re, and use of medicine thereof |
| 01/26/2000 | CN1242367A Spiro [Piperidine-4,1'-pyrrolo[3,4-c] pyrrole] |
| 01/26/2000 | CN1242366A Diaza-spiro [3,5] nonane derivatives |
| 01/26/2000 | CN1242217A Traditional Chinese medicine compositions contg. pueraria root extract |
| 01/26/2000 | CN1048728C 3-substituted 3H,-2,3-benzodiazepine derivatives, their prepn. and use as medicine |
| 01/25/2000 | US6018062 17-difluoromethylene-estratrienes |
| 01/25/2000 | US6018025 Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd528 as a target |
| 01/25/2000 | US6017953 Treating ocular hypotension, hypertension, hemorrhage, myocardial ischemia, angina pectoris, coronary contraction, cerebrovascular contraction after subarachnoidal hemorrhage, and asthma |
| 01/25/2000 | US6017952 Endothelin receptor antagonists |
| 01/25/2000 | US6017945 Useful in the treatment of restenosis, renal failure and pulmonary hypertension |
| 01/25/2000 | US6017916 Nonpeptide endothelin antagonists I |
| 01/25/2000 | US6017889 Metalloproteinase inhibitors |
| 01/25/2000 | US6017879 Template associated NPY Y2-receptor agonists |
| 01/25/2000 | US6017768 For screening agonists or antagonists of alpha adrenergic receptors, dopamine receptors, sigma opiate receptors, potassium ion channels, carbonic anhydrase inhibitors; for treatment of glaucoma |
| 01/25/2000 | US6017763 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/25/2000 | US6017728 ribH |
| 01/25/2000 | CA2117466C Application of 2-amino 6-trifluoromethoxy benzothiazole for obtaining a drug useful in the treatment of motor neuron diseases |
| 01/25/2000 | CA2091994C Complexes of nitric oxide with polyamines |
| 01/20/2000 | WO2000003036A1 Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe |
| 01/20/2000 | WO2000002998A1 Methods for implanting cells |
| 01/20/2000 | WO2000002912A2 Disintegrin homologs |
| 01/20/2000 | WO2000002911A2 INTERACTION OF HUMAN BETA AMYLOID PRECURSOR PROTEIN (β-APP) WITH HUMAN LON-PROTEASE LIKE PROTEIN (HSLON) |
| 01/20/2000 | WO2000002904A1 Matrix metalloproteinase inhibitors containing aminomalonic acid derivatives and peptide backbone modified derivatives thereof |
| 01/20/2000 | WO2000002902A1 Novel inhibitors of angiogenesis and tumor growth |
| 01/20/2000 | WO2000002881A2 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein |
| 01/20/2000 | WO2000002877A2 New pharmaceutically active compounds |
| 01/20/2000 | WO2000002871A1 Novel angiogenesis inhibitors |
| 01/20/2000 | WO2000002865A1 Pharmaceutical agents |
| 01/20/2000 | WO2000002860A1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them |
| 01/20/2000 | WO2000002851A1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 01/20/2000 | WO2000002850A2 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 01/20/2000 | WO2000002588A1 Targeted site specific drug delivery compositions and method of use |
| 01/20/2000 | WO2000002576A2 Egf-genistein for prevention of restenosis |
| 01/20/2000 | WO2000002558A1 Use of prenyltransferase inhibitors for preparing a medicine for treating pathologies resulting from heterotrimeric g protein membrane fixation |
| 01/20/2000 | WO2000002543A2 Antihypersensitive combination of valsartan and calcium channel blocker |
| 01/20/2000 | WO2000002541A1 Transdermal plaster containing at least one active ingredient which influences blood serum lipid levels |
| 01/20/2000 | WO2000002537A1 Composition containing glycerol trinitrate, method for producing said composition and use of the same |
| 01/20/2000 | WO2000002500A1 Cardiac disease treatment device and method |
| 01/20/2000 | WO2000002455A1 Hypericin and hypericum extract: specific t-type calcium channel blocker, and their use as t-type calcium channel targeted therapeutics |
| 01/20/2000 | WO1999053943A3 Therapeutic angiogenic factors and methods for their use |
| 01/20/2000 | WO1999053052A3 Srebp-2-deficient cell lines |
| 01/20/2000 | WO1999051742A3 Dadd, death activator death domain protein |
| 01/20/2000 | WO1999048858A3 Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents |
| 01/20/2000 | DE19832429A1 New imidazolylmethyl-biphenyl-sulfonylcyanamides, are sodium-dependent bicarbonate/chloride exchanger inhibitors used e.g. for treating cardiovascular disorders such as cardiac infarction |
| 01/20/2000 | DE19832428A1 New imidazolylmethyl-biphenyl-sulfonylcyanamides, are sodium-dependent bicarbonate/chloride exchanger inhibitors used e.g. for treating cardiovascular disorders such as cardiac infarction |
| 01/20/2000 | DE19832009A1 New 2,5-disubstituted benzenesulfonyl-ureas or -thioureas, used as ATP-sensitive potassium channel blockers for treating cardiovascular disorders such as arrhythmia or cardiac insufficiency |
| 01/20/2000 | DE19831710A1 New diacyl-hydrazine derivatives, are integrin inhibitors useful for treating e.g. thrombosis, cardiac infarction, tumors, osteoporosis, inflammation or infection |
| 01/20/2000 | CA2337795A1 Pharmaceutical agents |
| 01/20/2000 | CA2337438A1 Novel inhibitors of angiogenesis and tumor growth |
| 01/20/2000 | CA2337261A1 Use of prenyltransferase inhibitors for preparing a medicine for treating pathologies resulting from heterotrimeric g protein membrane fixation |
| 01/20/2000 | CA2337258A1 2-aminopyridine derivatives, their use as medicines and pharmaceutical compositions containing them |
| 01/20/2000 | CA2337164A1 Cardiac disease treatment device and method |
| 01/20/2000 | CA2336848A1 Novel angiogenesis inhibitors |
| 01/20/2000 | CA2336704A1 Composition containing glycerol trinitrate, method for producing said composition and use of the same |
| 01/20/2000 | CA2335382A1 Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe |
| 01/20/2000 | CA2332625A1 Interaction of human beta amyloid precursor protein (.beta.-app) with human lon-protease like protein (hslon) |
| 01/20/2000 | CA2332311A1 Disintegrin homologs |
| 01/19/2000 | EP0972837A2 Ubiquitin specific protease like protein |
| 01/19/2000 | EP0972780A1 Il-6 antagonist peptides |
| 01/19/2000 | EP0972515A2 Cyclooxygenase Inhibitor |
| 01/19/2000 | EP0972075A2 Methods for assessing cardiovascular status and compositions for use thereof |
| 01/19/2000 | EP0972053A1 Novel human serine carboxypeptidase |
| 01/19/2000 | EP0972044A1 Chemokine beta-6 |
| 01/19/2000 | EP0972041A1 Novel human delta3 compositions and therapeutic and diagnostic uses therefor |
| 01/19/2000 | EP0972040A1 Human gtp binding protein |
| 01/19/2000 | EP0972034A1 Bi- or multifunctional molecules based on a dendroaspin scaffold |
| 01/19/2000 | EP0972028A1 Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof |
| 01/19/2000 | EP0972020A1 Insulin-like growth factor agonist peptides |
| 01/19/2000 | EP0971961A1 N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation |
| 01/19/2000 | EP0971948A2 Inhibitors for urokinase receptor |
| 01/19/2000 | EP0971917A1 Thiazolidinedione and oxazolidinedione derivatives having antidiabetic, hypolipidaemic and antihypertensive properties |
| 01/19/2000 | EP0971908A1 Il-8 receptor antagonists |
| 01/19/2000 | EP0971895A1 Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor |
| 01/19/2000 | EP0971891A1 Thrombin inhibitors |
| 01/19/2000 | EP0971882A1 Nitro-benzamide useful as anti-arrhythmic agent |
| 01/19/2000 | EP0971880A1 Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-aminoethanesulfonic acid |
| 01/19/2000 | EP0971706A2 Vascular remodeling agent |
| 01/19/2000 | EP0971601A1 Decaffeinated mate extracts and the use thereof |
| 01/19/2000 | EP0966227A4 Composition containing a radioactive component for treatment of vessel wall |
| 01/19/2000 | EP0847240A4 Novel embolizing compositions |
| 01/19/2000 | EP0728144B1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases |
| 01/19/2000 | EP0726899B1 Novel pyrazine carboxamide derivatives, their production and their use in medicaments |
| 01/19/2000 | CN1242006A Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 01/19/2000 | CN1242001A Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 01/19/2000 | CN1241999A Vitamin D3 derivatives |
| 01/19/2000 | CN1241997A Nitromethylthiobenzene derivatives as inhibitors of aldose reductase |
| 01/19/2000 | CN1241558A Bicyclic aromatic compound and its application in human medicines or animal medicines and cosmetics teconology |